Antipsychotic effects of N-desmethylclozapine on sensorimotor gating function in rats - Possible involvement of activation of M 1 muscarinic receptors

European Journal of Pharmacology

Volumn 667, Issue 1-3, 2011, Pages 242-249

  Maehara, Shunsuke ^a,b   Satow, Akio ^a   Hikichi, Hirohiko ^a   Ohta, Hisashi ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Clozapine; M 1 muscarinic receptor; N desmethylclozapine; Prepulse inhibition; Schizophrenia

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR; KETAMINE; METHAMPHETAMINE; MUSCARINIC M1 RECEPTOR; NORCLOZAPINE; PROLACTIN; RACLOPRIDE; SCOPOLAMINE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; VOLINANSERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; RECEPTOR BLOCKING; SCHIZOPHRENIA; SENSORY GATING; STARTLE REFLEX;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CLOZAPINE; KETAMINE; MALE; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M1; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; SCOPOLAMINE HYDROBROMIDE; SENSORY GATING; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS;

EID: 80052024632     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.05.063     Document Type: Article

References (31)

1. M. Aravagiri, and S.R. Marder Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients J. Pharm. Biomed. Anal. 26 2001 301 311 (Pubitemid 32709945)
2. D.E. Baldessarini, and F.R. Frankenburg Clozapine a novel antipsychotic agent N. Engl. J. Med. 324 1991 746 754
3. R.J. Baldessarini, F. Centorrino, J.G. Flood, S.A. Volpicelli, D. Huston-Lyons, and B.M. Cohen Tissue concentrations of clozapine and its metabolites in the rat Neuropsychopharmacology 9 1993 117 124 (Pubitemid 23275837)
4. N. Ben-Jonathan Dopamine: a prolactin-inhibiting hormone Endocr. Rev. 6 1985 564 589
5. 1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices Mol. Cell. Neurosci. 18 2001 512 524 (Pubitemid 34008391)
6. C. Bolden, B. Cusack, and E. Richelson Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells J. Pharmacol. Exp. Ther. 260 1992 576 580
7. J. Gerlach, and L. Peacock Motor and mental side-effects of clozapine J. Clin. Psychiatry 55 1994 107 109
8. M.A. Geyer, K. Krebs-Thomson, and G.B. Varty The effects of M100907 in pharmacological and developmental animal models of prepulse inhibition deficits in schizophrenia Neuropsychopharmacology 21 1999 S134 S142
9. C. Guitton, J.M. Kinowski, R. Gomeni, and F. Bressolle A kinetic model for simultaneous fit of clozapine and norclozapine concentrations in chronic schizophrenic patients during long-term treatment Clin. Drug Investig. 16 1998 35 43 (Pubitemid 28362473)
10. C.K. Jones, and H.E. Shannon Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex J. Pharmacol. Exp. Ther. 294 2000 1017 1023 (Pubitemid 30666854)
11. C.K. Jones, E.L. Eberle, D.B. Shaw, D.L. McKinzie, and H.E. Shannon Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats J. Pharmacol. Exp. Ther. 312 2005 1055 1063 (Pubitemid 40293764)
12. S. Kapur, and G. Remington Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia Annu. Rev. Med. 52 2001 503 517 (Pubitemid 32195338)
13. 1C receptor antagonists Eur. J. Pharmacol. 245 1993 179 182 (Pubitemid 23115053)
14. J. Lameh, E.S. Burstein, E. Taylor, D.M. Weiner, K.E. Vanover, and D.W. Bonhaus Pharmacology of N-desmethylclozapine Pharmacol. Ther. 115 2007 223 231 (Pubitemid 47042913)
15. 1 muscarinic receptors Neuropsychopharmacology 30 2005 1986 1995 (Pubitemid 43093499)
16. S. Maehara, H. Hikichi, A. Satow, O. Shoki, and H. Ohta Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia Pharmacol. Biochem. Behav. 91 2008 140 149
17. H.Y. Meltzer The mechanism of action of novel antipsychotic drugs Schizophr. Bull. 17 1991 263 287
18. H.Y. Meltzer An overview of the mechanism of action of clozapine J. Clin. Psychiatry 55 1994 47 52 (Pubitemid 24353016)
19. S. Natesan, G.E. Reckless, K.B. Barlow, J.N. Nobrega, and S. Kapur Evaluation of N-desmethylclozapine as a potential antipsychotic-preclinical studies Neuropsychopharmacology 32 2007 1540 1549 (Pubitemid 46920156)
20. R. Peterson Scopolamine induced leaning failures in man Psychopharmacology 52 1977 283 289
21. J.M. Rusted, and D.M. Warburton The effects of scopolamine on working memory in healthy young volunteers Psychopharmacology 96 1988 145 152
22. A. Safferman, J. Lieberman, and J. Kane Update on clinical efficacy and side-effects of clozapine Schizophr. Bull. 17 1991 247 262
23. 2C receptors Behav. Pharmacol. 6 1995 839 842
24. K.J. Stanhope, N.R. Mirza, M.J. Bickerdike, J.L. Bright, N.R. Harrington, M.B. Hesselink, G.A. Kennett, S. Lightowler, M.J. Sheardown, R. Syed, R.L. Upton, G. Wadsworth, S.M. Weiss, and A. Wyatt The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat J. Pharmacol. Exp. Ther. 299 2001 782 792
25. C. Sur, P.J. Mallorga, M. Wittmann, M.A. Jacobson, D. Pascarella, J.B. Williams, P.E. Brandish, D.J. Pettibone, E.M. Scolnick, and P.J. Conn N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-d-aspartate receptor activity Proc. Natl. Acad. Sci. 100 2003 13674 13679 (Pubitemid 37444798)
26. N.R. Swerdlow, V. Bakshi, M. Waikar, N. Taaid, and M.A. Geyer Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats Psychopharmacology 140 1998 75 80 (Pubitemid 28524310)
27. G.B. Varty, and G.A. Higgins Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs Psychopharmacology 122 1995 15 26
28. 2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats Neuropsychopharmacology 20 1999 311 321 (Pubitemid 29099762)
29. J. Volavka, P. Czobor, B. Sheitman, J.P. Lindenmayer, L. Citrome, J.P. McEvoy, T.B. Cooper, M. Chakos, and J.A. Lieberman Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder Am. J. Psychiatry 159 2002 255 262 (Pubitemid 34126903)
30. H. Weigmann, S. Härtter, V. Fischer, N. Dahmen, and C. Hiemke Distribution of clozapine and desmethylclozapine between blood and brain in rats Eur. Neuropsychopharmacol. 9 1999 253 256 (Pubitemid 29114932)
31. D.M. Weiner, H.Y. Meltzer, I. Veinbergs, E.M. Donohue, T.A. Spalding, T.T. Smith, N. Mohell, S.C. Harvey, J. Lameh, N. Nash, K.E. Vanover, R. Olsson, K. Jayathilake, M. Lee, A.I. Levey, U. Hacksell, E.S. Burstein, R.E. Davis, and M.R. Brann The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine Psychopharmacology 177 2004 207 216 (Pubitemid 40109932)